キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/21 | 2,501 | 2,533 | 2,501 | 2,530 | +11 | +0.4% | 69,000 |
2023/02/20 | 2,531 | 2,542 | 2,517 | 2,519 | -7 | -0.3% | 28,300 |
2023/02/17 | 2,527 | 2,541 | 2,522 | 2,526 | -14 | -0.6% | 52,100 |
2023/02/16 | 2,550 | 2,561 | 2,540 | 2,540 | +14 | +0.6% | 41,300 |
2023/02/15 | 2,554 | 2,555 | 2,504 | 2,526 | -27 | -1.1% | 24,400 |
2023/02/14 | 2,509 | 2,553 | 2,509 | 2,553 | +74 | +3% | 45,800 |
2023/02/13 | 2,478 | 2,490 | 2,468 | 2,479 | -11 | -0.4% | 23,800 |
2023/02/10 | 2,473 | 2,502 | 2,466 | 2,490 | +7 | +0.3% | 43,400 |
2023/02/09 | 2,476 | 2,490 | 2,475 | 2,483 | -4 | -0.2% | 24,000 |
2023/02/08 | 2,471 | 2,499 | 2,471 | 2,487 | +16 | +0.6% | 33,600 |
2023/02/07 | 2,484 | 2,500 | 2,471 | 2,471 | -13 | -0.5% | 49,100 |
2023/02/06 | 2,487 | 2,492 | 2,455 | 2,484 | +24 | +1% | 77,900 |
2023/02/03 | 2,582 | 2,582 | 2,434 | 2,460 | -145 | -5.6% | 171,000 |
2023/02/02 | 2,640 | 2,668 | 2,599 | 2,605 | -25 | -1% | 96,400 |
2023/02/01 | 2,655 | 2,707 | 2,624 | 2,630 | +75 | +2.9% | 76,300 |
2023/01/31 | 2,538 | 2,564 | 2,538 | 2,555 | +22 | +0.9% | 53,000 |
2023/01/30 | 2,550 | 2,565 | 2,530 | 2,533 | -17 | -0.7% | 65,500 |
2023/01/27 | 2,546 | 2,557 | 2,527 | 2,550 | -3 | -0.1% | 42,300 |
2023/01/26 | 2,559 | 2,565 | 2,550 | 2,553 | ±0 | ±0% | 42,000 |
2023/01/25 | 2,563 | 2,571 | 2,534 | 2,553 | -17 | -0.7% | 56,500 |
2023/01/24 | 2,553 | 2,580 | 2,536 | 2,570 | +28 | +1.1% | 54,300 |
2023/01/23 | 2,548 | 2,556 | 2,535 | 2,542 | +8 | +0.3% | 52,200 |
2023/01/20 | 2,502 | 2,543 | 2,502 | 2,534 | +29 | +1.2% | 29,200 |
2023/01/19 | 2,519 | 2,545 | 2,500 | 2,505 | -14 | -0.6% | 33,700 |
2023/01/18 | 2,481 | 2,523 | 2,481 | 2,519 | +42 | +1.7% | 50,000 |
2023/01/17 | 2,462 | 2,480 | 2,457 | 2,477 | +15 | +0.6% | 27,300 |
2023/01/16 | 2,431 | 2,472 | 2,431 | 2,462 | +13 | +0.5% | 28,100 |
2023/01/13 | 2,457 | 2,482 | 2,444 | 2,449 | -16 | -0.6% | 50,000 |
2023/01/12 | 2,459 | 2,485 | 2,456 | 2,465 | +6 | +0.2% | 42,700 |
2023/01/11 | 2,459 | 2,503 | 2,459 | 2,459 | +6 | +0.2% | 51,400 |
2023/01/10 | 2,467 | 2,503 | 2,452 | 2,453 | -12 | -0.5% | 45,000 |
2023/01/06 | 2,484 | 2,492 | 2,456 | 2,465 | -22 | -0.9% | 45,700 |
2023/01/05 | 2,513 | 2,524 | 2,485 | 2,487 | -37 | -1.5% | 64,200 |
2023/01/04 | 2,550 | 2,553 | 2,498 | 2,524 | -56 | -2.2% | 53,600 |
2022/12/30 | 2,603 | 2,615 | 2,575 | 2,580 | -23 | -0.9% | 42,800 |
2022/12/29 | 2,562 | 2,604 | 2,556 | 2,603 | +19 | +0.7% | 32,300 |
2022/12/28 | 2,550 | 2,594 | 2,533 | 2,584 | +23 | +0.9% | 39,400 |
2022/12/27 | 2,583 | 2,602 | 2,551 | 2,561 | -23 | -0.9% | 14,700 |
2022/12/26 | 2,600 | 2,603 | 2,573 | 2,584 | -24 | -0.9% | 38,300 |
2022/12/23 | 2,598 | 2,617 | 2,581 | 2,608 | +54 | +2.1% | 94,400 |
2022/12/22 | 2,535 | 2,554 | 2,514 | 2,554 | +32 | +1.3% | 44,800 |
2022/12/21 | 2,514 | 2,536 | 2,500 | 2,522 | +4 | +0.2% | 58,300 |
2022/12/20 | 2,528 | 2,553 | 2,496 | 2,518 | +12 | +0.5% | 73,900 |
2022/12/19 | 2,520 | 2,520 | 2,495 | 2,506 | -36 | -1.4% | 29,100 |
2022/12/16 | 2,538 | 2,554 | 2,528 | 2,542 | -17 | -0.7% | 61,400 |
2022/12/15 | 2,534 | 2,563 | 2,534 | 2,559 | +15 | +0.6% | 27,800 |
2022/12/14 | 2,527 | 2,544 | 2,525 | 2,544 | +25 | +1% | 30,100 |
2022/12/13 | 2,522 | 2,532 | 2,506 | 2,519 | +17 | +0.7% | 30,800 |
2022/12/12 | 2,461 | 2,506 | 2,458 | 2,502 | +6 | +0.2% | 45,200 |
2022/12/09 | 2,500 | 2,517 | 2,496 | 2,496 | -18 | -0.7% | 44,100 |
551~
600
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 188,900円 | +5.9% | +24.5% | 2.91% | 12.53倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム